Cancer Articles
A recent study of an experimental therapy that alters cancer patients’ own immune cells to recognize an often deadly form of leukemia has shrunk tumors and sent the cancer into remission in adults.
A Phase II clinical trial that is testing the success of a pancreatic cancer vaccine is giving researchers hope that the treatment might be ready for wide distribution within the next couple of years.
Metastatic prostate cancer patients who received an investigational vaccine made from their own frozen immune cells lived 10 months longer than those not treated with it, according to data presented by researchers at the Kimmel Cancer Center at Jefferson.
A vaccine that jump-starts the immune system is showing promise in keeping patients diagnosed with glioblastoma, or malignant glioma, alive longer.
New research reveals that patients suffering from both breast cancer and arthritis have a more aggressive cancer, a finding that could suggest a possible treatment.
U.S. Army Col. George Peoples, chief of surgical oncology at the San Antonio Military Medical Center, says he has come up with a vaccine he thinks will prevent cancer.
A genetically engineered smallpox vaccine reduced the risk of death for patients with advanced liver cancer by nearly 60 percent in a mid-stage study.
Panacea Biotec, an India-based biotechnology firm, has introduced a generic breast cancer treatment medicine called PacliALL.
The U.S.Food and Drug Administration has approved a novel type of cancer vaccine called Yervoy.
Researchers from the Royal Women’s Hospital and Monash University in Melbourne, Australia, are testing immune modulation therapy to treat ovarian cancer.
The Cancer Research Institute has launched the Cancer Vaccine Acceleration Fund to speed the clinical development of therapeutic cancer vaccines and other immune system-based therapies.
A new cancer test is sensitive enough to spot a single cancer cell among a billion healthy cells, which may offer a better way to screen for the disease than methods currently used.